SLC2A9 and hypouricemia, renal: Later, clinical data showed that GLUT9 and URAT1 mutations in human lead to renal hypouricemia involving uric acid reabsorption dysfunction in the proximal tubule (24); meanwhile, benzbromarone and probenecid could inhibit the urate-induced expression of GLUT9 (25).